Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program

被引：0

作者：

Winthrop, Kevin L. ^{[1
]}

Loftus, Edward V., Jr. ^{[2
]}

Baumgart, Daniel C. ^{[3
]}

Hart, Ailsa ^{[4
]}

Alharbi, Othman R. ^{[5
]}

Salese, Leonardo ^{[6
]}

Lawendy, Nervin ^{[6
]}

Mundayat, Rajiv ^{[7
]}

Su, Chinyu ^{[6
]}

Reinisch, Walter ^{[8
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Mayo Clin, Coll Med, Rochester, MN USA

[3] Univ Alberta, Edmonton, AB, Canada

[4] St Marks Hosp, London, England

[5] King Khalid Univ Hosp, Riyadh, Ar Riyad, Saudi Arabia

[6] Pfizer Inc, Collegeville, PA USA

[7] Pfizer Inc, New York, NY USA

[8] Med Univ Vienna, Vienna, Austria

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S0644

引用

页码：S323 / S323

页数：1